Hive General Discourse

	Main Index Search Register Login Who's Online FAQ Links
	Main Index Search Register Login Who's Online FAQ Links

	2 Online, 0 Active		You are not logged in

This is a historical archiveThe forum is read-only. Private information has been removed. It is not possible to login.

	General Discourse

All 2 posts Subject: Drugs and Human Performance Fact Sheets Please login to post Down

merbst
(Hive Bee)
08-23-04 19:52
No 526972
Drugs and Human Performance Fact Sheets

National Highway Traffic Safety Administration - Drugs and Human
Performance Fact Sheets
http://www.nhtsa.dot.gov/people/injury/research/job185drugs/introduction.htm

Introduction
The use of psychoactive drugs followed by driving has been an issue of continual concern to law enforcement officers, physicians, attorneys, forensic toxicologists and traffic safety professionals in the U.S. and throughout the world. At issue are methods for identifying the impaired driver on the road, the assessment and documentation of the impairment they display, the availability of appropriate chemical tests, and the interpretation of the subsequent results. A panel of international experts on drug-related driving issues met to review developments in the field of drugs and human performance over the last 10 years; to identify the specific effects that both illicit and prescription drugs have on driving; and to develop guidance for others when dealing with drug-impaired driving problems.

This publication is based on the deliberations of the International Consultative Panel on Drugs and Driving Impairment held in Seattle, WA in August 2000. This meeting was sponsored by the National Safety Council, Committee on Alcohol and other Drugs; the State of Washington Traffic Safety Commission; and the National Highway Traffic Safety Administration. Delegates represented the fields of psychopharmacology, behavioral psychology, drug chemistry, forensic toxicology, medicine, and law enforcement experts trained in the recognition of drug effects on drivers in the field. The Fact Sheets reflect the conclusions of the Panel and have been designed to provide practical guidance to toxicologists, pharmacologists, law enforcement officers, attorneys and the general public on issues related to drug impaired driving.

Sixteen drugs were selected for review and include over-the-counter medications, prescription drugs, and illicit and/or abused drugs. The selected drugs are cannabis/marijuana, carisoprodol, cocaine, dextromethorphan, diazepam, diphenhydramine, gamma-hydroxybutyrate, ketamine, lysergic acid diethylamide, methadone, methamphetamine/amphetamine, methylenedioxymethamphetmaine, morphine/heroin, phencyclidine, toluene, and zolpidem.

The Fact Sheets are based on the state of current scientific knowledge and represent the conclusions of the panel. They have been designed to provide practical guidance to toxicologists, pharmacologists, law enforcement officers, attorneys and the general public to use in the evaluation of future cases. Each individual drug Fact Sheet covers information regarding drug chemistry, usage and dosage information, pharmacology, drug effects, effects on driving, drug evaluation and classification (DEC), and the panel’s assessment of driving risks. A list of key references and recommended reading is also provided for each drug. Readers are encouraged to use the Fact Sheets in connection with the other cited impaired driving-related texts.

The information provided is uniform for all the Fact Sheets and provides details on the physical description of the drug, synonyms, and pharmaceutical or illicit sources; medical and recreational uses, recommended and abused doses, typical routes of administration, and potency and purity; mechanism of drug action and major receptor sites; drug absorption, distribution, metabolism and elimination data; blood and urine concentrations; psychological and physiological effects, and drug interactions; drug effects on psychomotor performance effects; driving simulator and epidemiology studies; and drug recognition evaluation profiles. Each Fact Sheet concludes with general statements about the drugs’ ability to impair driving performance. The authors strongly believe that all the above information needs to be taken into account when evaluating a drug.

Case interpretation can be complicated by a number of factors and one of the main limitations of the Fact Sheets is that they primarily relate to single drug use. Other factors which influence the risk of effects on driving for any drug include the dose, the dosage frequency, acute and residual effects, chronic administration, route of administration, the concentration of the drug at the site of action, idiosyncrasies of metabolism, drug tolerance or hypersensitivity, and the combined effects of the drug with other drugs or alcohol, to name but a few.

Individual Fact Sheets
Cannabis/Marijuana
Carisoprodol (and Meprobamate)
Cocaine
Dextromethorphan
Diazepam
Diphenhydramine
Gamma-Hydroxybutyrate (GHB, GBL, and 1,4-BD)
Ketamine
Lysergic acid diethylamide (LSD)
Methadone
Methamphetamine (and Amphetamine)
Methylenedioxymethamphetamine (MDMA, Ecstasy)
Morphine (and Heroin)
Phencyclidine (PCP)
Toluene
Zolpidem (and Zaleplon, Zopiclone)

http://www.nhtsa.dot.gov/people/injury/research/job185drugs/drugs_web.pdf
2737-drugs_web.pdf

Local copy:

Fascinating! Actually there are MANY more interesting articles on this site:
http://www.nhtsa.dot.gov/people/injury/research/drug_impaired.html

Field Test of On-Site Drug Detection Devices (http://www.nhtsa.dot.gov/people/injury/research/pub/onsitedetection/Drug_index.htm)

State of Knowledge of Drug-Impaired Driving report (http://www.nhtsa.dot.gov/people/injury/research/StateofKnwlegeDrugs/StateofKnwlegeDrugs/index.html)
This literature review covers scientific studies on drugged driving published since 1980. Over 300 documents were reviewed, including research from other countries. The report includes the detection and measurement of drugs in drivers, experimental research, epidemiologic research, and drug-crash countermeasures

Antihistamines and Driving-Related Behavior: A Review of the Evidence for Impairment (http://www.nhtsa.dot.gov/people/injury/research/antihistamines/Antihistamines%20Web/index.htm)

12cheman12
(Hive Bee)
08-24-04 09:46
No 527074
How can anyone believe any of the shit these...

How can anyone believe any of the shit these guys say when they cant even get simple facts right...

"Performance Effects: LSD produces significant psychedelic effects with doses as little as 25-50 mg. LSD impairs reaction time (auditory and visual), choice reaction time, and visual acuity for up to 4 hours. Impaired divided attention, ataxia, and grossly distorted perception have also been reported following LSD use

no worries fuck head, you take 50 mgs LSD and we'll see how good you can drive.

Your an individual just like everyone else

	https://the-hive.archive.erowid.org	the-hive@erowid.org



Powdered by Aether^® V. 0.17.3, (C) 2019, BS-Soft Society
Links Erowid Rhodium

	All 2 posts		Subject: Drugs and Human Performance Fact Sheets		Please login to post		Down


		merbst (Hive Bee) 08-23-04 19:52 No 526972				Drugs and Human Performance Fact Sheets
						National Highway Traffic Safety Administration - Drugs and Human Performance Fact Sheets http://www.nhtsa.dot.gov/people/injury/research/job185drugs/introduction.htm Introduction The use of psychoactive drugs followed by driving has been an issue of continual concern to law enforcement officers, physicians, attorneys, forensic toxicologists and traffic safety professionals in the U.S. and throughout the world. At issue are methods for identifying the impaired driver on the road, the assessment and documentation of the impairment they display, the availability of appropriate chemical tests, and the interpretation of the subsequent results. A panel of international experts on drug-related driving issues met to review developments in the field of drugs and human performance over the last 10 years; to identify the specific effects that both illicit and prescription drugs have on driving; and to develop guidance for others when dealing with drug-impaired driving problems. This publication is based on the deliberations of the International Consultative Panel on Drugs and Driving Impairment held in Seattle, WA in August 2000. This meeting was sponsored by the National Safety Council, Committee on Alcohol and other Drugs; the State of Washington Traffic Safety Commission; and the National Highway Traffic Safety Administration. Delegates represented the fields of psychopharmacology, behavioral psychology, drug chemistry, forensic toxicology, medicine, and law enforcement experts trained in the recognition of drug effects on drivers in the field. The Fact Sheets reflect the conclusions of the Panel and have been designed to provide practical guidance to toxicologists, pharmacologists, law enforcement officers, attorneys and the general public on issues related to drug impaired driving. Sixteen drugs were selected for review and include over-the-counter medications, prescription drugs, and illicit and/or abused drugs. The selected drugs are cannabis/marijuana, carisoprodol, cocaine, dextromethorphan, diazepam, diphenhydramine, gamma-hydroxybutyrate, ketamine, lysergic acid diethylamide, methadone, methamphetamine/amphetamine, methylenedioxymethamphetmaine, morphine/heroin, phencyclidine, toluene, and zolpidem. The Fact Sheets are based on the state of current scientific knowledge and represent the conclusions of the panel. They have been designed to provide practical guidance to toxicologists, pharmacologists, law enforcement officers, attorneys and the general public to use in the evaluation of future cases. Each individual drug Fact Sheet covers information regarding drug chemistry, usage and dosage information, pharmacology, drug effects, effects on driving, drug evaluation and classification (DEC), and the panel’s assessment of driving risks. A list of key references and recommended reading is also provided for each drug. Readers are encouraged to use the Fact Sheets in connection with the other cited impaired driving-related texts. The information provided is uniform for all the Fact Sheets and provides details on the physical description of the drug, synonyms, and pharmaceutical or illicit sources; medical and recreational uses, recommended and abused doses, typical routes of administration, and potency and purity; mechanism of drug action and major receptor sites; drug absorption, distribution, metabolism and elimination data; blood and urine concentrations; psychological and physiological effects, and drug interactions; drug effects on psychomotor performance effects; driving simulator and epidemiology studies; and drug recognition evaluation profiles. Each Fact Sheet concludes with general statements about the drugs’ ability to impair driving performance. The authors strongly believe that all the above information needs to be taken into account when evaluating a drug. Case interpretation can be complicated by a number of factors and one of the main limitations of the Fact Sheets is that they primarily relate to single drug use. Other factors which influence the risk of effects on driving for any drug include the dose, the dosage frequency, acute and residual effects, chronic administration, route of administration, the concentration of the drug at the site of action, idiosyncrasies of metabolism, drug tolerance or hypersensitivity, and the combined effects of the drug with other drugs or alcohol, to name but a few. Individual Fact Sheets Cannabis/Marijuana Carisoprodol (and Meprobamate) Cocaine Dextromethorphan Diazepam Diphenhydramine Gamma-Hydroxybutyrate (GHB, GBL, and 1,4-BD) Ketamine Lysergic acid diethylamide (LSD) Methadone Methamphetamine (and Amphetamine) Methylenedioxymethamphetamine (MDMA, Ecstasy) Morphine (and Heroin) Phencyclidine (PCP) Toluene Zolpidem (and Zaleplon, Zopiclone) http://www.nhtsa.dot.gov/people/injury/research/job185drugs/drugs_web.pdf 2737-drugs_web.pdf Local copy: Fascinating! Actually there are MANY more interesting articles on this site: http://www.nhtsa.dot.gov/people/injury/research/drug_impaired.html Field Test of On-Site Drug Detection Devices (http://www.nhtsa.dot.gov/people/injury/research/pub/onsitedetection/Drug_index.htm) State of Knowledge of Drug-Impaired Driving report (http://www.nhtsa.dot.gov/people/injury/research/StateofKnwlegeDrugs/StateofKnwlegeDrugs/index.html) This literature review covers scientific studies on drugged driving published since 1980. Over 300 documents were reviewed, including research from other countries. The report includes the detection and measurement of drugs in drivers, experimental research, epidemiologic research, and drug-crash countermeasures Antihistamines and Driving-Related Behavior: A Review of the Evidence for Impairment (http://www.nhtsa.dot.gov/people/injury/research/antihistamines/Antihistamines%20Web/index.htm)



		12cheman12 (Hive Bee) 08-24-04 09:46 No 527074				How can anyone believe any of the shit these...
						How can anyone believe any of the shit these guys say when they cant even get simple facts right... "Performance Effects: LSD produces significant psychedelic effects with doses as little as 25-50 mg. LSD impairs reaction time (auditory and visual), choice reaction time, and visual acuity for up to 4 hours. Impaired divided attention, ataxia, and grossly distorted perception have also been reported following LSD use no worries fuck head, you take 50 mgs LSD and we'll see how good you can drive. Your an individual just like everyone else

All 2 posts	End of thread	Top